(1)
Hussein, R. G.; Al-Atrakji, M. Q. Impact of Infliximab Biosimilar (Ixifi®) Trough Levels on Disease Activity and Inflammatory Markers in Iraqi Rheumatoid Arthritis Patients. Al-Rafidain J Med Sci 2024, 7, S36-40.